Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP is senior vice president, Medical Affairs for the American Diabetes Association (ADA). In this role he leads and develops programs that advance evidence-based standards in diabetes care. He has also assumed expanded duties while the ADA conducts a comprehensive search for a new chief scientific and medical officer (CSMO).

Prior to joining the ADA staff, Josh served as a member of the ADA’s board of directors. He was also previously Chair and Allen I. White Distinguished Professor in the Department of Pharmacotherapy at Washington State University and Lead Pharmacist Researcher at Providence Medical Research Center in Spokane, Washington. Josh is past Editor-in-Chief for the ADA journal Diabetes Spectrum, co-Editor for the ADA book Medications for the Treatment of Diabetes, and author of Practical Insulin. 

Josh has served on multiple ADA committees and work groups and notably served as Chairman of the ADA’s Professional Practice Committee from 2018–2019, whose primary responsibility is revising the ADA Standards of Medical Care in Diabetes each year. Josh’s clinical, research, and service interests involve improving uptake and use of guideline-directed medical therapies in people with diabetes and chronic kidney disease, and he is a former investigator with the Center for Kidney Disease Research, Education and Hope (CURE-CKD). Josh was honored with the 2024 ADA Outstanding Educator in Diabetes Award and the 2025 Rachmiel Levine Medal for his service to ADA and work in diabetes care, research, and education.